Disney announced its first theme park in the Middle East is coming to Abu Dhabi. Fans haven’t just been guessing about the ...

The SVP of International Operations at DCTCM discusses Dubai’s unified tourism strategy, growing global appeal and ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

MEGA PRIME FOODS, Inc. is targeting an initial public offering (IPO) within the next two to three years as part of its long-term growth strategy, while seeking to expand its sardines market share this ...

Bechtel today signed an agreement with the King Salman International Airport Development Company to serve as the delivery ...

To further strengthen its relationship with Indian investors, RAKEZ maintains a dedicated branch office in Mumbai, ensuring ...

Wes Streeting spoke at the launch of the Centre for Policy Research for Men and Boys (CPRMB) on Tuesday 13 May It is a ...

As DP, Parsons will provide project management services for all phases of both contracts including early development, design, ...

Catalysts anchor Julie Hyman and guest host, Great Hill Capital chairman and managing member Thomas Hayes, cover a wide array ...

NetReputation.com, a leading innovator in online reputation management, today announced a record-breaking year in 2024, achieving over $19 million in gross revenue, marking a 30% year-over-year ...

Microsoft began laying off about 6,000 workers Tuesday, its largest job cuts in more than two years as the company spends ...

About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.